Tags » Hep C

Prevent hep C

Cover story published in Shifa News, July 2016

Hepatitis C:  Prevention is better than cure

24 year old, Umair was feeling pain in his body on his wedding day but he ignored it considering it to be due to the hectic routine. 1,183 more words

Non Fiction

Revealed: hep C treatment in prison

Editor’s note: While this blog follows Gideon Walletsky’s time in prison, it’s important to remember that many of his experiences are shared by thousands of inmates across the United States. 932 more words



Update: Bruce has a family who has committed to adopt him! Thank the Lord :)

This is Bruce! He is an adorable three year old little boy with HIV and Hep C on his file. 254 more words

Harvoni, Sovaldi, Viekira Pak, And Other Direct-Acting Antivirals Get Black-Box Warning: Risk Of Hepatitis B Virus Reactivation - Drug Injury Watch

Returning to the “FDA Drug Safety Communication: FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C”, which was issued on October 4, 2016:FDA identified 24 cases of HBV reactivation reported to FDA and from the published literature in HCV/HBV co-infected patients treated with DAAs during the 31 months from November 22, 2013 to July 18, 2016. 81 more words


Conflicts of Interest Abound in Hepatitis C Treatment Guidelines - Hep

A recent investigation into the Institute of Medicine (IOM) has revealed that several committee members tasked with setting official hepatitis C virus (HCV) treatment guidelines in 2015 had significant conflicts of interest involving the pharmaceutical and health care industries.  103 more words


FDA Adds Boxed Warning to Hepatitis C Drugs, Warns of Hepatitis B Reactivation Risk | RAPS

The US Food and Drug Administration (FDA) on Tuesday warned of serious risks for some patients who have been infected with the hepatitis B virus (HBV) and are being treated with certain direct-acting antiviral (DAA) medicines for hepatitis C virus (HCV).FDA identified 24 cases of HBV reactivation reported to FDA and from the published literature in HCV/HBV co-infected patients treated with DAAs between 22 November 2013 and 18 July 2016.Of the cases reported, two patients died and one required a liver transplant, though FDA cautions that this number includes only cases submitted to FDA, so there are likely additional cases. 16 more words


Petition · Dr. Janet Woodcock: The FDA Must Disclose All Potential Side Effects of Harvoni, Hepatitis C Medication · Change.org

It is estimated that 150 million people world-wide may have the Hepatitis C Virus. On October 10, 2014, the FDA approved the fixed-dose combination capsule of ledipasvir plus sofosbuvir (Harvoni; Gilead Sciences) for the treatment of patients with chronic HCV genotype 1 infection. 79 more words